Sector
Healthcare
35 articles
NVO
Novo Nordisk Price War: -2.6% Stock Pressure After CagriSema Shock
Novo Nordisk price war, CagriSema shock, and stock plunge: How hard does the GLP-1 double blow hit the market leader and what does it…
NVO
Novo Nordisk CagriSema -2.6%: Pipeline Shock and Price War
Novo Nordisk CagriSema flops in Phase 3, stock -2.6%: What does the study shock and price war for Wegovy and Ozempic mean?